More articles from Guidelines to Practice

  • Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines
    Priya Sasankan, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 700-703; DOI: https://doi.org/10.3949/ccjm.89a.22059

    Updated guidelines from the American College of Gastroenterology address the evaluation and management of reflux disease, consequences of long-term PPI therapy, and emerging therapies.

  • Update on pneumococcal vaccination in adults: Simpler is better
    Craig D. Nielsen, MD, FACP, Joel A. Kammeyer, MD, MPH, FACP and Michael J. Tan, MD, FACP, FIDSA
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 640-642; DOI: https://doi.org/10.3949/ccjm.89a.22047

    Recommendations have been updated in the hopes not only of preventing more cases of invasive pneumococcal disease, but also of making the recommendations easier to follow.

  • Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidance
    Glenn T. Werneburg, MD, PhD and Daniel D. Rhoads, MD
    Cleveland Clinic Journal of Medicine October 2022, 89 (10) 581-587; DOI: https://doi.org/10.3949/ccjm.89a.22008

    New guidance on ordering, processing, and reporting urine cultures focuses on reducing unnecessary antibiotic use and the misdiagnosis of urinary tract infection.

  • Managing stage 1 hypertension: Consider the risks, stop the progression
    Abel Hooker, MD, Kevin G. Buda, DO and Maarya Pasha, MD
    Cleveland Clinic Journal of Medicine May 2022, 89 (5) 244-248; DOI: https://doi.org/10.3949/ccjm.89a.21101

    Guidelines on managing patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.

  • Anaphylaxis: Highlights from the practice parameter update
    Katherine N. Weller, MD and Fred H. Hsieh, MD
    Cleveland Clinic Journal of Medicine February 2022, 89 (2) 106-111; DOI: https://doi.org/10.3949/ccjm.89a.21076

    The update addresses diagnostic criteria, treatment options, prevention of recurrences, and patient education on avoiding triggers and using self-injectable epinephrine.

  • Updated guidelines for immune thrombocytopenic purpura: Expanded management options
    Sherwin DeSouza, MD and Dana Angelini, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

    The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  • Risk-based guidelines: Redefining management of abnormal cervical cancer screening results
    Amy Wiser, MD, FAAFP, Jeffrey D. Quinlan, MD, FAAFP and Pelin Batur, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 556-560; DOI: https://doi.org/10.3949/ccjm.88a.20193

    A shift from results-based to risk-based management, based on the patient’s immediate and 5-year risks of grade 3 or higher cervical intraepithelial neoplasia.

  • Outpatient management of asthma in adults: A snapshot of the 2020 GINA report
    Kavya Kommaraju, MD and Mani Latifi, MD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 377-380; DOI: https://doi.org/10.3949/ccjm.88a.20167

    A review of the guidelines, with a focus on what’s new and clinically important.

  • Reversal of direct oral anticoagulants: Highlights from the Anticoagulation Forum guideline
    Haeshik S. Gorr, MD, Lucy Yun Lu, PharmD, MS and Eric Hung, PharmD, CACP, AE-C
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 98-103; DOI: https://doi.org/10.3949/ccjm.88a.19133

    Clear instructions on how to manage DOAC-associated bleeding.